Bayesian Capital Management, LP Abiomed Inc Transaction History

Bayesian Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$141.4 - $257.09 $452,480 - $822,687	-3,200 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$130.51 - $196.01 $417,632 - $627,232	3,200 New	3,200 $465,000
Q2 2019 Aug 13, 2019	SELL	$250.96 - $284.94 $1.63 Million - $1.85 Million	-6,506 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$276.39 - $362.25 $1.8 Million - $2.36 Million	6,506 New	6,506 $1.86 Million
Q3 2018 Nov 14, 2018	SELL	$354.53 - $449.75 $574,693 - $729,044	-1,621 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$278.07 - $446.21 $61,453 - $98,612	221 Added 15.79%	1,621 $663,000
Q1 2018 May 15, 2018	BUY	$192.49 - $295.85 $269,486 - $414,190	1,400 New	1,400 $407,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.